Understanding TB-500 Dosing in Research
TB-500 is a synthetic fragment of Thymosin Beta-4 (T?4), a naturally occurring 43-amino acid peptide involved in tissue repair, cell migration, and angiogenesis. This dosage guide covers the research protocols, loading schedules, and scientific findings from published studies on this regenerative peptide.
TB-500 vs Thymosin Beta-4
TB-500 contains the active region of full-length Thymosin Beta-4, specifically the actin-binding domain (amino acids 17-23: LKKTETQ). This region is responsible for the peptide’s key biological activities including upregulation of actin, cell migration promotion, and anti-inflammatory signaling.
Research Dosing Protocols
Published research on TB-500 and Thymosin Beta-4 has utilized both loading and maintenance phase protocols.
Loading Phase
- Dose: 2-5mg administered twice weekly via subcutaneous injection
- Duration: 4-6 weeks
- Total weekly dose: 4-10mg during loading
- Purpose: Establish therapeutic tissue concentrations
Maintenance Phase
- Dose: 2-5mg administered once every 1-2 weeks
- Duration: Variable based on research endpoints
- Purpose: Maintain elevated T?4 levels in target tissues
Reconstitution & Preparation
TB-500 is supplied as a lyophilized powder. Reconstitute with bacteriostatic water using sterile technique. Standard reconstitution uses 1-2mL per vial. Calculate injection volumes based on desired dose and reconstitution concentration. Our reconstitution guide provides detailed calculations.
Combination Research: TB-500 + BPC-157
A significant body of research has examined TB-500 alongside BPC-157, as the two peptides act through complementary mechanisms. BPC-157 promotes angiogenesis and nitric oxide signaling, while TB-500 enhances actin organization and cell migration. The Wolverine Blend combines both peptides for researchers studying these synergistic pathways. See our TB-500 vs BPC-157 comparison for detailed mechanism analysis.
Dose-Response Research Findings
Animal model research has demonstrated dose-dependent effects of Thymosin Beta-4 on tissue repair processes. Key observations include enhanced migration of keratinocytes and endothelial cells, increased matrix metalloproteinase activity, and upregulation of anti-inflammatory cytokines — all showing dose-response relationships within the studied ranges.
Storage & Handling
Store lyophilized TB-500 at -20°C to 4°C. Reconstituted solution should be refrigerated at 2-8°C and used within 2-3 weeks. Avoid repeated freeze-thaw cycles. See our peptide storage guide for comprehensive handling protocols.
Safety Observations in Research
TB-500 research has reported a favorable safety profile. The most commonly noted observations include mild injection site reactions and transient fatigue. As a fragment of an endogenous protein, TB-500’s safety profile benefits from the body’s familiarity with Thymosin Beta-4.
This material is for research and educational purposes only. TB-500 is sold for research use only. Verify purity at our COA page.
Related Articles
All products are sold strictly for research purposes only. Not for human consumption.